Formulate

Find pharma jobs. Prep for interviews like no one else can.

Browse

Jobs Companies Drugs Indications Career Advisor About

Insider Intel

Intelligence Hub Therapeutic Areas Contribute Intro Network Salary Explorer For Employers Pricing

Legal

argenx Jobs | Formulate

Jobs
argenx

argenx Jobs

Belgium - Zwijnaarde

Biotechnology

argenx is a life sciences company focused on Antibody therapies.

84 open positions at argenx

View Full Profile

Market Head, Texas

argenx

Posted 3w ago

United States - Field

$236K - $325K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Business Leader, Northeast (Upstate NY & Southern NE)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Business Leader, New York Metro (New York)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Business Leader, Midwest (Chicago Metro)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Business Leader, South Central (Mid South)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Business Leader, Midwest (Midwest)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Business Leader, Rocky Plains (Rocky Mountains)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Business Leader, Southeast (Peachtree)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Business Leader, Florida & Puerto Rico (South Florida)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Business Leader, Southeast (South Atlantic)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Market Head, Midwest

argenx

Posted 3w ago

United States - Field

$236K - $325K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Senior Director, Emerging Science and Pipeline Marketing Community Lead

argenx

Posted 3w ago

Remote

$236K - $325K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteCommercialNeurologyExecutive

H-1B · 1 FY23

Business Leader, Florida & Puerto Rico (North Florida)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Business Leader, Southwest (Las Vegas Metro)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

NeurologyMID

H-1B · 1 FY23

Market Head, Great Lakes

argenx

Posted 3w ago

United States - Field

$236K - $325K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Business Leader, Northeast (New England)

argenx

Posted 3w ago

United States - Field

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

NeurologyMID

H-1B · 1 FY23

Manager Internal Controls

argenx

Posted 1mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMANAGER

H-1B · 1 FY23

Trial Operations Excellence & Innovation Lead

argenx

Posted 1mo ago

Remote

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Franchise Clinical Operations Development Lead (CODL)

argenx

Posted 1mo ago

Remote

$268K - $369K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteClinical OperationsImmunologySenior

H-1B · 1 FY23

Associate Director Regulatory CMC – Development

argenx

Posted 1mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Regulatory AffairsImmunologyExecutive

H-1B · 1 FY23

Company Overview

Active Jobs

Pipeline Programs

Drug Products

Clinical Trials

View Full Company Profile

Therapeutic Areas

Neurology Immunology Oncology

Links

Company Website Careers Page

Hematology

Rare Diseases